My reason for holding is the fact they increased revenue by 32% while increasing expenses by 8%. This puts us in a strong position in FY 19 & going forward, and bring us close to positive net profits. I remind you that we are already making a positive operating cash flows, which will only go in one direction due to revenue is growing faster than expenses and at a good rate. These are my calcs for FY 19 & FY 20, D&A, taxes ignored.H1 FY19, revenue grew 24% faster than expenses, I am assuming H2 to be 15% as per the table above.
FY19 is already showing a massive turnaround in EBIDTA and FY 20 is likely to be a year of ultimate success with possible dividends given the revenue growth is sustained to these levels and expenses growth is constrained up to 50% of revenue growth.
FY 20 is also projected at 25% revenue growth and 10% expenses growth.
I also think the share is trading at a massive discount based on discounted free cash flows, these are my calculations:
If we continue to grow & keep our expenses growth up to 50% of the revenue growth, CAT should have the intrinsic value of $3.01. Even if I got it wrong by 20%, the fundamental value comes to $2.40.
I wouldn't sell if the CEO / CFO has or both have resigned. It simply means the job is up for grabs, and the change is always interesting.
DYOR !!
- Forums
- ASX - By Stock
- CAT
- Ann: CEO Resignation and Transition Arrangements
Ann: CEO Resignation and Transition Arrangements, page-134
-
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CAT (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.46 |
Change
0.070(2.06%) |
Mkt cap ! $638.2M |
Open | High | Low | Value | Volume |
$3.41 | $3.51 | $3.40 | $946.7K | 272.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 1790 | $3.44 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.46 | 2119 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.980 |
1 | 4986 | 0.970 |
1 | 1036 | 0.965 |
2 | 32659 | 0.960 |
2 | 41512 | 0.940 |
Price($) | Vol. | No. |
---|---|---|
0.990 | 1 | 1 |
1.000 | 42518 | 3 |
1.010 | 10000 | 1 |
1.020 | 25000 | 1 |
1.040 | 18507 | 4 |
Last trade - 10.38am 25/11/2024 (20 minute delay) ? |
Featured News
CAT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online